Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • ELCC 2018

    The 8th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland

    Presentation Date(s):  
    • Apr 11 - 14, 2018
    • Total Presentations: 407

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    Uncommon driver alterations: Should we use off-label targeted agents?

    • Type: Controversy session
    • Presentations: 4
    • Moderators:E. Smit
    • Coordinates: 4/12/2018, 09:15 - 10:15, Room A
  • +

    Next generation TKI: Frontline or later?

    • Type: Controversy session
    • Presentations: 4
    • Moderators:S. Ramalingam
    • Coordinates: 4/13/2018, 09:15 - 10:15, Room A
  • +

    Guiding the best targeted treatment

    • Type: Multidisciplinary Tumour Board
    • Presentations: 3
    • Moderators:E. Smit
    • Coordinates: 4/13/2018, 14:45 - 16:15, Room A
    • +

      Can we rely on liquid biopsy for treatment decision at the time of acquired resistance?

      14:45 - 15:15  |  Presenter: J. Remon-Masip

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EGFR activating mutation plus exon 20 co-mutation at baseline: Which TKI should we select for frontline treatment?

      15:15 - 15:45  |  Presenter: E. Smit

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Progression on osimertinib: When is it possible to continue with a targeted therapy?

      15:45 - 16:15  |  Presenter: D. Planchard

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.